Trimetazidine manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

trimetazidine

Tablets 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #23786
Founded in the 1950s with nearly seven decades of pharmaceutical leadership, this integrated pharma company is among the top players in its home market. Rx and OTC portfolio spans branded generics, biosimilars, APIs, and novel drugs across oncology, metabolic, cardiac, and infectious disease therapy areas. US FDA and EU-GMP approved facilities operate across multiple continents.

trimetazidine

Capsules, extended release (ER) 80 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Available for
Technology transfer
Manufacturer #36888
A pharmaceutical manufacturer-oriented contract research and development organisation that provides formulation, analytical, bioequivalence, technology transfer and related development services to support the creation and regulatory approval of pharmaceutical products in many dosage forms including tablets, capsules, liquids, ointments, transdermal systems and parenteral solutions. The company works with clients to assist in pharmaceutical development and manufacturing objectives, offering integrated support from concept through development to compliance and commercial readiness.

trimetazidine

Tablets, modified release (MR) 35 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Comments
API source: In-House
Manufacturer #36459

Established in 2018, this manufacturer employs approximately 653 individuals and specializes in offering end-to-end solutions in the pharmaceutical and specialty chemicals industries. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple international regulatory authorities, including the U.S. FDA, the Therapeutic Goods Administration (TGA) of Australia, and the Malta Medicines Authority (European Union). Additionally, it has received Written Confirmation from the Central Drugs Standard Control Organization (CDSCO) in India, affirming compliance with EU GMP standards for active pharmaceutical ingredients. The manufacturer operates advanced production lines for active pharmaceutical ingredients (APIs) and formulations, adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products and services are utilized across various countries and regions worldwide. With a focus on innovation, efficiency, and agility, the manufacturer is committed to delivering high-standard products that enhance the quality of people's lives.

 

 

 

 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.